Genentech Executive Vice President Wins Lasker Award
-- Richard Scheller Recognized for Seminal Advances in Neuroscience --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Richard Scheller, Ph.D., Executive Vice President, Research and Early Development, is a winner of the 2013 Albert Lasker Basic Medical Research Award, given annually to a scientist whose fundamental investigations have provided techniques, information or concepts contributing to the elimination of major causes of disability and death.
The Lasker Awards are among the most renowned science prizes in the world and have become popularly known as "America's Nobels." Dr. Scheller shares this year's award with Thomas Südhof, Professor of Molecular and Cellular Physiology at Stanford University, for their discoveries concerning rapid neurotransmitter release, a process that underlies all of the brain's activities. Dr. Scheller is donating his proceeds from the award to the Wildlife Conservation Network, a San Francisco Bay Area-based organization dedicated to protecting endangered species and preserving their natural habitats.
Dr. Scheller is a member of Genentech's executive committee and the Enlarged Roche Corporate Executive Committee. He is responsible for overseeing the strategy for Genentech's research, drug discovery, business development and early development activities. Prior to joining Genentech in 2001, Dr. Scheller was Professor of Molecular and Cellular Physiology and Biological Science at Stanford University and an investigator with the Howard Hughes Medical Institute.
Dr. Scheller has published more than 200 papers in peer-reviewed scientific journals. He is a member of the Academy of Arts and Sciences and the National Academy of Sciences, and the recipient of numerous scientific awards including the 2010 Kavli Prize in Neuroscience. Scheller received his Bachelor of Science in biochemistry at the University of Wisconsin, Madison, where he received the Distinguished Alumni Award in 2009. He was awarded his doctorate in chemistry from the California Institute of Technology. He was a postdoctoral fellow at both the California Institute of Technology and Columbia University.
Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.
Robin Snyder, 650-467-6800 (Media)
Thomas Kudsk Larsen, 650-467-2016 (Investors)
Karl Mahler, 011 41 61 687 8503 (Investors)
KEYWORDS: United States North America California
The article Genentech Executive Vice President Wins Lasker Award originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.